(-)-UH 232
(-)-UH 232 is a central dopamine (DA) receptor agonist. (-)-UH 232 weakly decreases 3, 4-dihydroxyphenylalanine (DOPA) formation in striatal and limbic brain regions in rats. (-)-UH 232 can be used for the research of neurological diseases including parkinson's disease and schizophrenia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 95999-11-4
- Formel: C18H29NO
- Molecular Weight:275.44
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Dopamine Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley rats (male, 200-300 g)[1]
-
Dosage:0.8, 3.2, 13, 52, 204 μmol/kg
-
Administration:s.c.; single dose
-
Result:Failed to significantly influence locomotor activity in non-pretreated rats at doses up to 52 μmol/kg.
Did not antagonize Reserpine (HY-N0480)-induced hypomotility at 204 μmol/kg.
Produced a weak trend towards reduced cortical DOPA formation, with a significant 15% decrease only at 52 μmol/kg in non-pretreated rats.
Dose-dependently decreased DOPA formation in limbic and striatal regions of reserpinized rats.
Chemical Information
-
CAS. Nr. 95999-11-4
-
Molecular Weight 275.44
-
Formel C18H29NO
-
SMILES
O(C)C1=C2C([C@@H](C)[C@@H](N(CCC)CCC)CC2)=CC=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
- (-)-UH 232
- 95999-11-4
- Dopamine Receptor
- non-pretreated rats
- parkinson's disease
- reserpine-induced akinesia
- schizophrenia
- neurological diseases
- dopamine receptor modulation models
- striatum
- brain regions
- Sprague-Dawley rats
- reserpinized rats
- DOPA formation
- dopamine (DA) receptor agonist
- limbic region
- Inhibitor
- inhibitor
- inhibit